Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Received: 24 May 2017
Accepted: 26 May 2017
Published: 10 July 2017
The original article was published in Breast Cancer Research 2017 19:57
Erratum
This article [1] has been updated to correct the spelling of one of the author’s names. Donna Plecha’s name was incorrectly spelt as Pletcha when this article originally published.
Notes
Declarations
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Authors’ Affiliations
References
- Braman NM, Maryam E, Prateek P, Christina D, Hannah G, Pallavi T, Donna P, Anant M. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19:57. doi:10.1186/s13058-017-0846-1.View ArticlePubMedPubMed CentralGoogle Scholar
